JP2007535910A5 - - Google Patents

Download PDF

Info

Publication number
JP2007535910A5
JP2007535910A5 JP2006544559A JP2006544559A JP2007535910A5 JP 2007535910 A5 JP2007535910 A5 JP 2007535910A5 JP 2006544559 A JP2006544559 A JP 2006544559A JP 2006544559 A JP2006544559 A JP 2006544559A JP 2007535910 A5 JP2007535910 A5 JP 2007535910A5
Authority
JP
Japan
Prior art keywords
seq
derivative
polypeptide
analogue
analog
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006544559A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007535910A (ja
Filing date
Publication date
Priority claimed from GBGB0329254.7A external-priority patent/GB0329254D0/en
Application filed filed Critical
Publication of JP2007535910A publication Critical patent/JP2007535910A/ja
Publication of JP2007535910A5 publication Critical patent/JP2007535910A5/ja
Pending legal-status Critical Current

Links

JP2006544559A 2003-12-17 2004-12-17 ウイルス感染の治療 Pending JP2007535910A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0329254.7A GB0329254D0 (en) 2003-12-17 2003-12-17 Treatment of viral infections
PCT/GB2004/005360 WO2005058959A2 (en) 2003-12-17 2004-12-17 Treatment of viral infections

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012020504A Division JP2012115277A (ja) 2003-12-17 2012-02-02 ウイルス感染の治療

Publications (2)

Publication Number Publication Date
JP2007535910A JP2007535910A (ja) 2007-12-13
JP2007535910A5 true JP2007535910A5 (enExample) 2008-02-07

Family

ID=30471239

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006544559A Pending JP2007535910A (ja) 2003-12-17 2004-12-17 ウイルス感染の治療
JP2012020504A Pending JP2012115277A (ja) 2003-12-17 2012-02-02 ウイルス感染の治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012020504A Pending JP2012115277A (ja) 2003-12-17 2012-02-02 ウイルス感染の治療

Country Status (11)

Country Link
US (3) US7691382B2 (enExample)
EP (2) EP1709075B9 (enExample)
JP (2) JP2007535910A (enExample)
CN (2) CN1894281B (enExample)
AU (1) AU2004299343B8 (enExample)
CA (1) CA2548585A1 (enExample)
DK (1) DK1709075T3 (enExample)
ES (1) ES2389078T3 (enExample)
GB (1) GB0329254D0 (enExample)
PL (1) PL1709075T3 (enExample)
WO (1) WO2005058959A2 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0329254D0 (en) * 2003-12-17 2004-01-21 Univ Manchester Treatment of viral infections
GB0329958D0 (en) 2003-12-24 2004-01-28 Univ Manchester Treatment of viral infections
GB0404374D0 (en) * 2004-02-27 2004-03-31 Univ Manchester Treatment of bacterial infections
GB0513096D0 (en) * 2005-06-28 2005-08-03 Strathclyde Treatment of microbial infections
ES2543341T3 (es) 2005-09-13 2015-08-18 National Research Council Of Canada Métodos y composiciones para modular la actividad de células tumorales
PL2085774T3 (pl) * 2008-02-01 2018-08-31 Kraft Foods R & D, Inc. Sposób określania konsystencji materiału spożywczego
WO2009102715A2 (en) * 2008-02-11 2009-08-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Peptide therapy for ocular herpes infections
JP5553336B2 (ja) * 2008-02-14 2014-07-16 国立大学法人京都工芸繊維大学 ペプチド、当該ペプチドの用途及び生産方法並びに当該ペプチドが固定化された固相及びその生産方法
HRP20191129T1 (hr) 2009-11-24 2019-09-20 Alethia Biotherapeutics Inc. Anti-klusterinska protutijela i ulomci koji vežu antigen i njihova uporaba za smanjivanje volumena tumora
US20120053128A1 (en) * 2010-08-26 2012-03-01 Xavier University Method of inhibiting angiogenesis
WO2013013187A1 (en) 2011-07-21 2013-01-24 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Apolipoprotein e polypeptides and their use
EA201491568A1 (ru) 2012-02-22 2014-11-28 Алетиа Байотерапьютикс Инк. Совместное применение ингибитора кластерина и ингибитора egfr для лечения рака
WO2013148305A1 (en) * 2012-03-29 2013-10-03 Xavier University Of Louisiana Method for treating diabetic retinopathy
KR20170080579A (ko) 2014-10-01 2017-07-10 플랜트 헬스 케어, 인코포레이티드 파괴된 과민성 반응 박스를 갖는 유발제 펩티드 및 그의 용도
PL3201341T3 (pl) 2014-10-01 2025-09-01 Plant Health Care, Inc. Peptydy wywołujące reakcję nadwrażliwości i ich zastosowanie
US20170298100A1 (en) * 2014-10-01 2017-10-19 Cascadia Life Sciences Llc Anti-viral peptides
US11371011B2 (en) 2016-04-06 2022-06-28 Plant Health Care, Inc. Beneficial microbes for delivery of effector peptides or proteins and use thereof
US10793608B2 (en) 2016-04-06 2020-10-06 Plant Health Care, Inc. Hypersensitive response elicitor-derived peptides and use thereof
EP3962925A4 (en) * 2019-04-30 2023-08-23 Maxwell Biosciences, Inc. HALOGENATED ANTIMICROBIAL PEPTOIDS
CN116813712B (zh) * 2023-06-16 2024-03-29 东北农业大学 一种富含Trp的α-螺旋结构抗菌肽W33及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5473039A (en) * 1989-08-18 1995-12-05 The Scripps Research Institute Polypeptide analogs of apolipoprotein E, diagnostic systems and methods using the analogs
WO1993000443A1 (en) * 1991-06-26 1993-01-07 Bio-Technology General Corp. Purification of recombinant apolipoprotein e from bacteria
US5344822A (en) 1992-08-12 1994-09-06 The Rogosin Institute Methods useful in endotoxin prophylaxis and therapy
CA2304720A1 (en) * 1997-09-30 1999-04-08 Duke University Apolipoprotein e/growth factor complexes and methods of use
US7205280B2 (en) * 1998-03-11 2007-04-17 Cognosci, Inc. Methods of suppressing microglial activation
GB0200757D0 (en) * 2002-01-15 2002-02-27 Univ Manchester Diagnostic methods
GB0329254D0 (en) * 2003-12-17 2004-01-21 Univ Manchester Treatment of viral infections

Similar Documents

Publication Publication Date Title
JP2007535910A5 (enExample)
CN101553243B (zh) 组织损伤修复中的基质细胞衍生因子1的蛋白酶抗性突变体
JP2012115277A5 (enExample)
JP2004536077A5 (enExample)
JP2018171063A5 (enExample)
JP2012518035A5 (enExample)
JP2008511323A5 (enExample)
JP2013515057A5 (enExample)
JP2013515055A5 (enExample)
JP2011511753A5 (enExample)
JP2010524971A5 (enExample)
HUT70459A (en) Analogs of pth
JP2006514104A5 (enExample)
JP2010516688A (ja) 抗菌ペプチド
JP2013500990A5 (enExample)
HRP20110242T1 (hr) Formulacija s fuzijskim proteinom glp-1-fc
JP2010515686A5 (enExample)
RU2011134596A (ru) Аналоги оксинтомодулина
JP2014519852A5 (enExample)
JP2008507298A5 (enExample)
JP2011518179A5 (enExample)
JPWO2019156137A5 (enExample)
JP2006506942A5 (enExample)
JP2015504052A5 (enExample)
JP2010536714A5 (enExample)